0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vancomycin Market Research Report 2023
Published Date: June 2023
|
Report Code: QYRE-Auto-20N7760
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Vancomycin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Vancomycin Market Research Report 2023

Code: QYRE-Auto-20N7760
Report
June 2023
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Vancomycin Market

Vancomycin is an effective and safe antibiotic in the treatment of severe infections caused by methicillin-resistant staphylococcus aureus, methicillin-resistant coagulase-negative staphylococcus and enterococcus, including sepsis, pulmonary infection and skin and soft tissue infection.
The global Vancomycin market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Vancomycin is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Vancomycin is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Vancomycin include Pfizer, Eli Lilly and Company, CJ CheilJedang, Xellia Pharmaceuticals ApS, VIANEX, Alchemia Limited, Alvogen, Aphios Corporation and Cellceutix Corporation, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vancomycin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vancomycin.
The Vancomycin market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Vancomycin market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vancomycin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Scope of Vancomycin Market Report

Report Metric Details
Report Name Vancomycin Market
Segment by Type
  • Daptomycin
  • Linezolid
  • Quinupristin
  • Ampicillin
  • Chloramphenicol
  • Others
Segment by Application
  • Sepsis
  • Lung Infection
  • Skin Soft Tissue Infection
  • Colitis & Intestinal Inflammation
  • To Prevent Infection
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Eli Lilly and Company, CJ CheilJedang, Xellia Pharmaceuticals ApS, VIANEX, Alchemia Limited, Alvogen, Aphios Corporation, Cellceutix Corporation, Enanta Pharmaceuticals, Helix BioMedix, LegoChem Biosciences, Lytix Biopharma, MGB Biopharma Limited, Microbiotix., MicuRx Pharmaceuticals, Nabriva Therapeutics, NovaBay Pharmaceuticals, NovoBiotic Pharmaceuticals, Oragenics, Sealife Pharma, Taiwan Zhengde Pharmaceutical, Zhejiang Pharmaceutical, Zhejiang Haizheng Pharmaceutical, North China Pharmaceutical, Shenwei Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Vancomycin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Vancomycin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.
1 Vancomycin Market Overview
1.1 Product Overview and Scope of Vancomycin
1.2 Vancomycin Segment by Type
1.2.1 Global Vancomycin Market Value Comparison by Type (2023-2029)
1.2.2 Daptomycin
1.2.3 Linezolid
1.2.4 Quinupristin
1.2.5 Ampicillin
1.2.6 Chloramphenicol
1.2.7 Others
1.3 Vancomycin Segment by Application
1.3.1 Global Vancomycin Market Value by Application: (2023-2029)
1.3.2 Sepsis
1.3.3 Lung Infection
1.3.4 Skin Soft Tissue Infection
1.3.5 Colitis & Intestinal Inflammation
1.3.6 To Prevent Infection
1.4 Global Vancomycin Market Size Estimates and Forecasts
1.4.1 Global Vancomycin Revenue 2018-2029
1.4.2 Global Vancomycin Sales 2018-2029
1.4.3 Global Vancomycin Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Vancomycin Market Competition by Manufacturers
2.1 Global Vancomycin Sales Market Share by Manufacturers (2018-2023)
2.2 Global Vancomycin Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Vancomycin Average Price by Manufacturers (2018-2023)
2.4 Global Vancomycin Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Vancomycin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vancomycin, Product Type & Application
2.7 Vancomycin Market Competitive Situation and Trends
2.7.1 Vancomycin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vancomycin Players Market Share by Revenue
2.7.3 Global Vancomycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vancomycin Retrospective Market Scenario by Region
3.1 Global Vancomycin Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Vancomycin Global Vancomycin Sales by Region: 2018-2029
3.2.1 Global Vancomycin Sales by Region: 2018-2023
3.2.2 Global Vancomycin Sales by Region: 2024-2029
3.3 Global Vancomycin Global Vancomycin Revenue by Region: 2018-2029
3.3.1 Global Vancomycin Revenue by Region: 2018-2023
3.3.2 Global Vancomycin Revenue by Region: 2024-2029
3.4 North America Vancomycin Market Facts & Figures by Country
3.4.1 North America Vancomycin Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Vancomycin Sales by Country (2018-2029)
3.4.3 North America Vancomycin Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vancomycin Market Facts & Figures by Country
3.5.1 Europe Vancomycin Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Vancomycin Sales by Country (2018-2029)
3.5.3 Europe Vancomycin Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vancomycin Market Facts & Figures by Country
3.6.1 Asia Pacific Vancomycin Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Vancomycin Sales by Country (2018-2029)
3.6.3 Asia Pacific Vancomycin Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vancomycin Market Facts & Figures by Country
3.7.1 Latin America Vancomycin Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Vancomycin Sales by Country (2018-2029)
3.7.3 Latin America Vancomycin Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vancomycin Market Facts & Figures by Country
3.8.1 Middle East and Africa Vancomycin Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Vancomycin Sales by Country (2018-2029)
3.8.3 Middle East and Africa Vancomycin Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vancomycin Sales by Type (2018-2029)
4.1.1 Global Vancomycin Sales by Type (2018-2023)
4.1.2 Global Vancomycin Sales by Type (2024-2029)
4.1.3 Global Vancomycin Sales Market Share by Type (2018-2029)
4.2 Global Vancomycin Revenue by Type (2018-2029)
4.2.1 Global Vancomycin Revenue by Type (2018-2023)
4.2.2 Global Vancomycin Revenue by Type (2024-2029)
4.2.3 Global Vancomycin Revenue Market Share by Type (2018-2029)
4.3 Global Vancomycin Price by Type (2018-2029)
5 Segment by Application
5.1 Global Vancomycin Sales by Application (2018-2029)
5.1.1 Global Vancomycin Sales by Application (2018-2023)
5.1.2 Global Vancomycin Sales by Application (2024-2029)
5.1.3 Global Vancomycin Sales Market Share by Application (2018-2029)
5.2 Global Vancomycin Revenue by Application (2018-2029)
5.2.1 Global Vancomycin Revenue by Application (2018-2023)
5.2.2 Global Vancomycin Revenue by Application (2024-2029)
5.2.3 Global Vancomycin Revenue Market Share by Application (2018-2029)
5.3 Global Vancomycin Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Vancomycin Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Eli Lilly and Company
6.2.1 Eli Lilly and Company Corporation Information
6.2.2 Eli Lilly and Company Description and Business Overview
6.2.3 Eli Lilly and Company Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Eli Lilly and Company Vancomycin Product Portfolio
6.2.5 Eli Lilly and Company Recent Developments/Updates
6.3 CJ CheilJedang
6.3.1 CJ CheilJedang Corporation Information
6.3.2 CJ CheilJedang Description and Business Overview
6.3.3 CJ CheilJedang Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.3.4 CJ CheilJedang Vancomycin Product Portfolio
6.3.5 CJ CheilJedang Recent Developments/Updates
6.4 Xellia Pharmaceuticals ApS
6.4.1 Xellia Pharmaceuticals ApS Corporation Information
6.4.2 Xellia Pharmaceuticals ApS Description and Business Overview
6.4.3 Xellia Pharmaceuticals ApS Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Xellia Pharmaceuticals ApS Vancomycin Product Portfolio
6.4.5 Xellia Pharmaceuticals ApS Recent Developments/Updates
6.5 VIANEX
6.5.1 VIANEX Corporation Information
6.5.2 VIANEX Description and Business Overview
6.5.3 VIANEX Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.5.4 VIANEX Vancomycin Product Portfolio
6.5.5 VIANEX Recent Developments/Updates
6.6 Alchemia Limited
6.6.1 Alchemia Limited Corporation Information
6.6.2 Alchemia Limited Description and Business Overview
6.6.3 Alchemia Limited Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Alchemia Limited Vancomycin Product Portfolio
6.6.5 Alchemia Limited Recent Developments/Updates
6.7 Alvogen
6.6.1 Alvogen Corporation Information
6.6.2 Alvogen Description and Business Overview
6.6.3 Alvogen Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Alvogen Vancomycin Product Portfolio
6.7.5 Alvogen Recent Developments/Updates
6.8 Aphios Corporation
6.8.1 Aphios Corporation Corporation Information
6.8.2 Aphios Corporation Description and Business Overview
6.8.3 Aphios Corporation Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Aphios Corporation Vancomycin Product Portfolio
6.8.5 Aphios Corporation Recent Developments/Updates
6.9 Cellceutix Corporation
6.9.1 Cellceutix Corporation Corporation Information
6.9.2 Cellceutix Corporation Description and Business Overview
6.9.3 Cellceutix Corporation Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cellceutix Corporation Vancomycin Product Portfolio
6.9.5 Cellceutix Corporation Recent Developments/Updates
6.10 Enanta Pharmaceuticals
6.10.1 Enanta Pharmaceuticals Corporation Information
6.10.2 Enanta Pharmaceuticals Description and Business Overview
6.10.3 Enanta Pharmaceuticals Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Enanta Pharmaceuticals Vancomycin Product Portfolio
6.10.5 Enanta Pharmaceuticals Recent Developments/Updates
6.11 Helix BioMedix
6.11.1 Helix BioMedix Corporation Information
6.11.2 Helix BioMedix Vancomycin Description and Business Overview
6.11.3 Helix BioMedix Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Helix BioMedix Vancomycin Product Portfolio
6.11.5 Helix BioMedix Recent Developments/Updates
6.12 LegoChem Biosciences
6.12.1 LegoChem Biosciences Corporation Information
6.12.2 LegoChem Biosciences Vancomycin Description and Business Overview
6.12.3 LegoChem Biosciences Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.12.4 LegoChem Biosciences Vancomycin Product Portfolio
6.12.5 LegoChem Biosciences Recent Developments/Updates
6.13 Lytix Biopharma
6.13.1 Lytix Biopharma Corporation Information
6.13.2 Lytix Biopharma Vancomycin Description and Business Overview
6.13.3 Lytix Biopharma Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Lytix Biopharma Vancomycin Product Portfolio
6.13.5 Lytix Biopharma Recent Developments/Updates
6.14 MGB Biopharma Limited
6.14.1 MGB Biopharma Limited Corporation Information
6.14.2 MGB Biopharma Limited Vancomycin Description and Business Overview
6.14.3 MGB Biopharma Limited Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.14.4 MGB Biopharma Limited Vancomycin Product Portfolio
6.14.5 MGB Biopharma Limited Recent Developments/Updates
6.15 Microbiotix.
6.15.1 Microbiotix. Corporation Information
6.15.2 Microbiotix. Vancomycin Description and Business Overview
6.15.3 Microbiotix. Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Microbiotix. Vancomycin Product Portfolio
6.15.5 Microbiotix. Recent Developments/Updates
6.16 MicuRx Pharmaceuticals
6.16.1 MicuRx Pharmaceuticals Corporation Information
6.16.2 MicuRx Pharmaceuticals Vancomycin Description and Business Overview
6.16.3 MicuRx Pharmaceuticals Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.16.4 MicuRx Pharmaceuticals Vancomycin Product Portfolio
6.16.5 MicuRx Pharmaceuticals Recent Developments/Updates
6.17 Nabriva Therapeutics
6.17.1 Nabriva Therapeutics Corporation Information
6.17.2 Nabriva Therapeutics Vancomycin Description and Business Overview
6.17.3 Nabriva Therapeutics Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Nabriva Therapeutics Vancomycin Product Portfolio
6.17.5 Nabriva Therapeutics Recent Developments/Updates
6.18 NovaBay Pharmaceuticals
6.18.1 NovaBay Pharmaceuticals Corporation Information
6.18.2 NovaBay Pharmaceuticals Vancomycin Description and Business Overview
6.18.3 NovaBay Pharmaceuticals Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.18.4 NovaBay Pharmaceuticals Vancomycin Product Portfolio
6.18.5 NovaBay Pharmaceuticals Recent Developments/Updates
6.19 NovoBiotic Pharmaceuticals
6.19.1 NovoBiotic Pharmaceuticals Corporation Information
6.19.2 NovoBiotic Pharmaceuticals Vancomycin Description and Business Overview
6.19.3 NovoBiotic Pharmaceuticals Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.19.4 NovoBiotic Pharmaceuticals Vancomycin Product Portfolio
6.19.5 NovoBiotic Pharmaceuticals Recent Developments/Updates
6.20 Oragenics
6.20.1 Oragenics Corporation Information
6.20.2 Oragenics Vancomycin Description and Business Overview
6.20.3 Oragenics Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Oragenics Vancomycin Product Portfolio
6.20.5 Oragenics Recent Developments/Updates
6.21 Sealife Pharma
6.21.1 Sealife Pharma Corporation Information
6.21.2 Sealife Pharma Vancomycin Description and Business Overview
6.21.3 Sealife Pharma Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Sealife Pharma Vancomycin Product Portfolio
6.21.5 Sealife Pharma Recent Developments/Updates
6.22 Taiwan Zhengde Pharmaceutical
6.22.1 Taiwan Zhengde Pharmaceutical Corporation Information
6.22.2 Taiwan Zhengde Pharmaceutical Vancomycin Description and Business Overview
6.22.3 Taiwan Zhengde Pharmaceutical Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Taiwan Zhengde Pharmaceutical Vancomycin Product Portfolio
6.22.5 Taiwan Zhengde Pharmaceutical Recent Developments/Updates
6.23 Zhejiang Pharmaceutical
6.23.1 Zhejiang Pharmaceutical Corporation Information
6.23.2 Zhejiang Pharmaceutical Vancomycin Description and Business Overview
6.23.3 Zhejiang Pharmaceutical Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Zhejiang Pharmaceutical Vancomycin Product Portfolio
6.23.5 Zhejiang Pharmaceutical Recent Developments/Updates
6.24 Zhejiang Haizheng Pharmaceutical
6.24.1 Zhejiang Haizheng Pharmaceutical Corporation Information
6.24.2 Zhejiang Haizheng Pharmaceutical Vancomycin Description and Business Overview
6.24.3 Zhejiang Haizheng Pharmaceutical Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Zhejiang Haizheng Pharmaceutical Vancomycin Product Portfolio
6.24.5 Zhejiang Haizheng Pharmaceutical Recent Developments/Updates
6.25 North China Pharmaceutical
6.25.1 North China Pharmaceutical Corporation Information
6.25.2 North China Pharmaceutical Vancomycin Description and Business Overview
6.25.3 North China Pharmaceutical Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.25.4 North China Pharmaceutical Vancomycin Product Portfolio
6.25.5 North China Pharmaceutical Recent Developments/Updates
6.26 Shenwei Pharmaceutical
6.26.1 Shenwei Pharmaceutical Corporation Information
6.26.2 Shenwei Pharmaceutical Vancomycin Description and Business Overview
6.26.3 Shenwei Pharmaceutical Vancomycin Sales, Revenue and Gross Margin (2018-2023)
6.26.4 Shenwei Pharmaceutical Vancomycin Product Portfolio
6.26.5 Shenwei Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vancomycin Industry Chain Analysis
7.2 Vancomycin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vancomycin Production Mode & Process
7.4 Vancomycin Sales and Marketing
7.4.1 Vancomycin Sales Channels
7.4.2 Vancomycin Distributors
7.5 Vancomycin Customers
8 Vancomycin Market Dynamics
8.1 Vancomycin Industry Trends
8.2 Vancomycin Market Drivers
8.3 Vancomycin Market Challenges
8.4 Vancomycin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Vancomycin Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Vancomycin Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Vancomycin Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Vancomycin Sales (KG) of Key Manufacturers (2018-2023)
    Table 5. Global Vancomycin Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Vancomycin Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Vancomycin Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Vancomycin Average Price (US$/G) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Vancomycin, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Vancomycin, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Vancomycin, Product Type & Application
    Table 12. Global Key Manufacturers of Vancomycin, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Vancomycin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vancomycin as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Vancomycin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Vancomycin Sales by Region (2018-2023) & (KG)
    Table 18. Global Vancomycin Sales Market Share by Region (2018-2023)
    Table 19. Global Vancomycin Sales by Region (2024-2029) & (KG)
    Table 20. Global Vancomycin Sales Market Share by Region (2024-2029)
    Table 21. Global Vancomycin Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Vancomycin Revenue Market Share by Region (2018-2023)
    Table 23. Global Vancomycin Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Vancomycin Revenue Market Share by Region (2024-2029)
    Table 25. North America Vancomycin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Vancomycin Sales by Country (2018-2023) & (KG)
    Table 27. North America Vancomycin Sales by Country (2024-2029) & (KG)
    Table 28. North America Vancomycin Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Vancomycin Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Vancomycin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Vancomycin Sales by Country (2018-2023) & (KG)
    Table 32. Europe Vancomycin Sales by Country (2024-2029) & (KG)
    Table 33. Europe Vancomycin Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Vancomycin Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Vancomycin Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Vancomycin Sales by Region (2018-2023) & (KG)
    Table 37. Asia Pacific Vancomycin Sales by Region (2024-2029) & (KG)
    Table 38. Asia Pacific Vancomycin Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Vancomycin Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Vancomycin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Vancomycin Sales by Country (2018-2023) & (KG)
    Table 42. Latin America Vancomycin Sales by Country (2024-2029) & (KG)
    Table 43. Latin America Vancomycin Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Vancomycin Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Vancomycin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Vancomycin Sales by Country (2018-2023) & (KG)
    Table 47. Middle East & Africa Vancomycin Sales by Country (2024-2029) & (KG)
    Table 48. Middle East & Africa Vancomycin Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Vancomycin Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Vancomycin Sales (KG) by Type (2018-2023)
    Table 51. Global Vancomycin Sales (KG) by Type (2024-2029)
    Table 52. Global Vancomycin Sales Market Share by Type (2018-2023)
    Table 53. Global Vancomycin Sales Market Share by Type (2024-2029)
    Table 54. Global Vancomycin Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Vancomycin Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Vancomycin Revenue Market Share by Type (2018-2023)
    Table 57. Global Vancomycin Revenue Market Share by Type (2024-2029)
    Table 58. Global Vancomycin Price (US$/G) by Type (2018-2023)
    Table 59. Global Vancomycin Price (US$/G) by Type (2024-2029)
    Table 60. Global Vancomycin Sales (KG) by Application (2018-2023)
    Table 61. Global Vancomycin Sales (KG) by Application (2024-2029)
    Table 62. Global Vancomycin Sales Market Share by Application (2018-2023)
    Table 63. Global Vancomycin Sales Market Share by Application (2024-2029)
    Table 64. Global Vancomycin Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Vancomycin Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Vancomycin Revenue Market Share by Application (2018-2023)
    Table 67. Global Vancomycin Revenue Market Share by Application (2024-2029)
    Table 68. Global Vancomycin Price (US$/G) by Application (2018-2023)
    Table 69. Global Vancomycin Price (US$/G) by Application (2024-2029)
    Table 70. Pfizer Corporation Information
    Table 71. Pfizer Description and Business Overview
    Table 72. Pfizer Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 73. Pfizer Vancomycin Product
    Table 74. Pfizer Recent Developments/Updates
    Table 75. Eli Lilly and Company Corporation Information
    Table 76. Eli Lilly and Company Description and Business Overview
    Table 77. Eli Lilly and Company Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 78. Eli Lilly and Company Vancomycin Product
    Table 79. Eli Lilly and Company Recent Developments/Updates
    Table 80. CJ CheilJedang Corporation Information
    Table 81. CJ CheilJedang Description and Business Overview
    Table 82. CJ CheilJedang Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 83. CJ CheilJedang Vancomycin Product
    Table 84. CJ CheilJedang Recent Developments/Updates
    Table 85. Xellia Pharmaceuticals ApS Corporation Information
    Table 86. Xellia Pharmaceuticals ApS Description and Business Overview
    Table 87. Xellia Pharmaceuticals ApS Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 88. Xellia Pharmaceuticals ApS Vancomycin Product
    Table 89. Xellia Pharmaceuticals ApS Recent Developments/Updates
    Table 90. VIANEX Corporation Information
    Table 91. VIANEX Description and Business Overview
    Table 92. VIANEX Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 93. VIANEX Vancomycin Product
    Table 94. VIANEX Recent Developments/Updates
    Table 95. Alchemia Limited Corporation Information
    Table 96. Alchemia Limited Description and Business Overview
    Table 97. Alchemia Limited Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 98. Alchemia Limited Vancomycin Product
    Table 99. Alchemia Limited Recent Developments/Updates
    Table 100. Alvogen Corporation Information
    Table 101. Alvogen Description and Business Overview
    Table 102. Alvogen Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 103. Alvogen Vancomycin Product
    Table 104. Alvogen Recent Developments/Updates
    Table 105. Aphios Corporation Corporation Information
    Table 106. Aphios Corporation Description and Business Overview
    Table 107. Aphios Corporation Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 108. Aphios Corporation Vancomycin Product
    Table 109. Aphios Corporation Recent Developments/Updates
    Table 110. Cellceutix Corporation Corporation Information
    Table 111. Cellceutix Corporation Description and Business Overview
    Table 112. Cellceutix Corporation Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 113. Cellceutix Corporation Vancomycin Product
    Table 114. Cellceutix Corporation Recent Developments/Updates
    Table 115. Enanta Pharmaceuticals Corporation Information
    Table 116. Enanta Pharmaceuticals Description and Business Overview
    Table 117. Enanta Pharmaceuticals Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 118. Enanta Pharmaceuticals Vancomycin Product
    Table 119. Enanta Pharmaceuticals Recent Developments/Updates
    Table 120. Helix BioMedix Corporation Information
    Table 121. Helix BioMedix Description and Business Overview
    Table 122. Helix BioMedix Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 123. Helix BioMedix Vancomycin Product
    Table 124. Helix BioMedix Recent Developments/Updates
    Table 125. LegoChem Biosciences Corporation Information
    Table 126. LegoChem Biosciences Description and Business Overview
    Table 127. LegoChem Biosciences Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 128. LegoChem Biosciences Vancomycin Product
    Table 129. LegoChem Biosciences Recent Developments/Updates
    Table 130. Lytix Biopharma Corporation Information
    Table 131. Lytix Biopharma Description and Business Overview
    Table 132. Lytix Biopharma Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 133. Lytix Biopharma Vancomycin Product
    Table 134. Lytix Biopharma Recent Developments/Updates
    Table 135. MGB Biopharma Limited Corporation Information
    Table 136. MGB Biopharma Limited Description and Business Overview
    Table 137. MGB Biopharma Limited Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 138. MGB Biopharma Limited Vancomycin Product
    Table 139. MGB Biopharma Limited Recent Developments/Updates
    Table 140. Microbiotix. Corporation Information
    Table 141. Microbiotix. Description and Business Overview
    Table 142. Microbiotix. Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 143. Microbiotix. Vancomycin Product
    Table 144. Microbiotix. Recent Developments/Updates
    Table 145. MicuRx Pharmaceuticals Corporation Information
    Table 146. MicuRx Pharmaceuticals Description and Business Overview
    Table 147. MicuRx Pharmaceuticals Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 148. MicuRx Pharmaceuticals Vancomycin Product
    Table 149. MicuRx Pharmaceuticals Recent Developments/Updates
    Table 150. Nabriva Therapeutics Corporation Information
    Table 151. Nabriva Therapeutics Description and Business Overview
    Table 152. Nabriva Therapeutics Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 153. Nabriva Therapeutics Vancomycin Product
    Table 154. Nabriva Therapeutics Recent Developments/Updates
    Table 155. NovaBay Pharmaceuticals Corporation Information
    Table 156. NovaBay Pharmaceuticals Description and Business Overview
    Table 157. NovaBay Pharmaceuticals Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 158. NovaBay Pharmaceuticals Vancomycin Product
    Table 159. NovaBay Pharmaceuticals Recent Developments/Updates
    Table 160. NovoBiotic Pharmaceuticals Corporation Information
    Table 161. NovoBiotic Pharmaceuticals Description and Business Overview
    Table 162. NovoBiotic Pharmaceuticals Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 163. NovoBiotic Pharmaceuticals Vancomycin Product
    Table 164. NovoBiotic Pharmaceuticals Recent Developments/Updates
    Table 165. Oragenics Corporation Information
    Table 166. Oragenics Description and Business Overview
    Table 167. Oragenics Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 168. Oragenics Vancomycin Product
    Table 169. Oragenics Recent Developments/Updates
    Table 170. Sealife Pharma Corporation Information
    Table 171. Sealife Pharma Description and Business Overview
    Table 172. Sealife Pharma Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 173. Sealife Pharma Vancomycin Product
    Table 174. Sealife Pharma Recent Developments/Updates
    Table 175. Taiwan Zhengde Pharmaceutical Corporation Information
    Table 176. Taiwan Zhengde Pharmaceutical Description and Business Overview
    Table 177. Taiwan Zhengde Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 178. Taiwan Zhengde Pharmaceutical Vancomycin Product
    Table 179. Taiwan Zhengde Pharmaceutical Recent Developments/Updates
    Table 180. Zhejiang Pharmaceutical Corporation Information
    Table 181. Zhejiang Pharmaceutical Description and Business Overview
    Table 182. Zhejiang Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 183. Zhejiang Pharmaceutical Vancomycin Product
    Table 184. Zhejiang Pharmaceutical Recent Developments/Updates
    Table 185. Zhejiang Haizheng Pharmaceutical Corporation Information
    Table 186. Zhejiang Haizheng Pharmaceutical Description and Business Overview
    Table 187. Zhejiang Haizheng Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 188. Zhejiang Haizheng Pharmaceutical Vancomycin Product
    Table 189. Zhejiang Haizheng Pharmaceutical Recent Developments/Updates
    Table 190. North China Pharmaceutical Corporation Information
    Table 191. North China Pharmaceutical Description and Business Overview
    Table 192. North China Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 193. North China Pharmaceutical Vancomycin Product
    Table 194. North China Pharmaceutical Recent Developments/Updates
    Table 195. Shenwei Pharmaceutical Corporation Information
    Table 196. Shenwei Pharmaceutical Description and Business Overview
    Table 197. Shenwei Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
    Table 198. Shenwei Pharmaceutical Vancomycin Product
    Table 199. Shenwei Pharmaceutical Recent Developments/Updates
    Table 200. Key Raw Materials Lists
    Table 201. Raw Materials Key Suppliers Lists
    Table 202. Vancomycin Distributors List
    Table 203. Vancomycin Customers List
    Table 204. Vancomycin Market Trends
    Table 205. Vancomycin Market Drivers
    Table 206. Vancomycin Market Challenges
    Table 207. Vancomycin Market Restraints
    Table 208. Research Programs/Design for This Report
    Table 209. Key Data Information from Secondary Sources
    Table 210. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Vancomycin
    Figure 2. Global Vancomycin Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Vancomycin Market Share by Type in 2022 & 2029
    Figure 4. Daptomycin Product Picture
    Figure 5. Linezolid Product Picture
    Figure 6. Quinupristin Product Picture
    Figure 7. Ampicillin Product Picture
    Figure 8. Chloramphenicol Product Picture
    Figure 9. Others Product Picture
    Figure 10. Global Vancomycin Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 11. Global Vancomycin Market Share by Application in 2022 & 2029
    Figure 12. Sepsis
    Figure 13. Lung Infection
    Figure 14. Skin Soft Tissue Infection
    Figure 15. Colitis & Intestinal Inflammation
    Figure 16. To Prevent Infection
    Figure 17. Global Vancomycin Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 18. Global Vancomycin Market Size (2018-2029) & (US$ Million)
    Figure 19. Global Vancomycin Sales (2018-2029) & (KG)
    Figure 20. Global Vancomycin Average Price (US$/G) & (2018-2029)
    Figure 21. Vancomycin Report Years Considered
    Figure 22. Vancomycin Sales Share by Manufacturers in 2022
    Figure 23. Global Vancomycin Revenue Share by Manufacturers in 2022
    Figure 24. The Global 5 and 10 Largest Vancomycin Players: Market Share by Revenue in 2022
    Figure 25. Vancomycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 26. Global Vancomycin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 27. North America Vancomycin Sales Market Share by Country (2018-2029)
    Figure 28. North America Vancomycin Revenue Market Share by Country (2018-2029)
    Figure 29. U.S. Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. Canada Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Europe Vancomycin Sales Market Share by Country (2018-2029)
    Figure 32. Europe Vancomycin Revenue Market Share by Country (2018-2029)
    Figure 33. Germany Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. France Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. U.K. Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Italy Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. Russia Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. Asia Pacific Vancomycin Sales Market Share by Region (2018-2029)
    Figure 39. Asia Pacific Vancomycin Revenue Market Share by Region (2018-2029)
    Figure 40. China Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Japan Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. South Korea Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. India Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Australia Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Taiwan Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Indonesia Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Thailand Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Malaysia Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Philippines Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Latin America Vancomycin Sales Market Share by Country (2018-2029)
    Figure 51. Latin America Vancomycin Revenue Market Share by Country (2018-2029)
    Figure 52. Mexico Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Brazil Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Argentina Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 55. Middle East & Africa Vancomycin Sales Market Share by Country (2018-2029)
    Figure 56. Middle East & Africa Vancomycin Revenue Market Share by Country (2018-2029)
    Figure 57. Turkey Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 58. Saudi Arabia Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 59. UAE Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 60. Global Sales Market Share of Vancomycin by Type (2018-2029)
    Figure 61. Global Revenue Market Share of Vancomycin by Type (2018-2029)
    Figure 62. Global Vancomycin Price (US$/G) by Type (2018-2029)
    Figure 63. Global Sales Market Share of Vancomycin by Application (2018-2029)
    Figure 64. Global Revenue Market Share of Vancomycin by Application (2018-2029)
    Figure 65. Global Vancomycin Price (US$/G) by Application (2018-2029)
    Figure 66. Vancomycin Value Chain
    Figure 67. Vancomycin Production Process
    Figure 68. Channels of Distribution (Direct Vs Distribution)
    Figure 69. Distributors Profiles
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS